2005 Edition Report on Drug Administration Procedure & Practices ...

More documents

Recommendations

Info

複本 Antidotes and emeg drug list to hosp revised 28 April 08 Page 2 of 6 PagesAntidotes and Emergency Drug List April 2008LEVEL § ANTIDOTES & DETOXIFYING AGENT UNIT AHNH CMC KWH NDH PMH POH PWH PYNEH QEH QMH RHTSK SJH TKO TMH UCH YCH HKPIC ※39 Metaraminol Tartrate Aramine Inj. 10mg/ml x 1ml META04 ampI 40a Atropine Sulphate Inj. 0.6mg ATRO01 amp Y Y Y Y Y Y Y Y Y Y40b Atropine Sulphate Inj. 1.2mg ATRO03 amp Y Y Y Y Y41 Cardioplegia Inj 20ml CARD03 amp YI 42 Dantrolene Inj 1mg/ml 20ml DANT01 vial Y Y Y Y Y Y Y Y Y Y Y** Y Y Y Y43a Dopamine Inj. 50mg/5ml DOPA01 amp43b 200mg/5ml DOPA02 vial Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y44 Edrophonium Chloride Inj.10mg/ ml EDRO01 amp Y Y Y Y Y Y Y Y Y Y Y 0 Y Y Y Y45 Isoprenaline Inj. 1mg/5ml ISOP12 amp Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y46a Lignocaine Inj. 1% 50ml (1% 20ml for FH) LIGN02 vial Y Y Y Y Y Y Y Y Y Y Y Y Y46b 1% 5ml LIGN53 amp Y Y Y Y Y Y Y Y Y46c 1.5% 50ml LIGN03 vial47 Neostigmine 2.5mg/ml luer-fit NEOS06 vial Y Y Y Y Y Y Y Y Y Y Y Y Y Y YI 48 Pyridoxine Inj. (preservative free) 100mg/ml x 1ml PYRI13 amp Y Y Y Y Y Y Y Y Y* Y Y Y YI 49a Pyridoxine Inj. 50mg/ml 2ml PYRI14 amp Y 10049b Pyridoxine HCl (No preservative) Inj 100mg/ml x 10ml PYRI15 YD. SNAKE ANTIVENENE SERAIII 50 Agkistrodon Actus 2000u/amp,China AGKI02 amp 4 2 2 8 8 8II 51 Agkistrodon halys 6000u/amp,China AGKI03 amp 2 4 2 2 4 4 4 4 6 4 1II 52 Bungarus Multicinctus antivenin Inj 10000u/amp BUNG02 amp 2 2 2 8 2 4 5 5 2 4 4 2III 53 Cobra Antivenene 0.6mg/ml,Thailand COBR01 vial 2 2 5* 6 8 8 454 Green Pit Viper 0.6mg/ml, Thailand GREE01 vial 4 4 8 3* 10 4 4 6 1255 King Cobra Antivene 1mg/ml, Thailand KING01 vial 10* 6 8 8 3 3III 56 Krait Banded 0.6mg/ml Thailand KRAI01 vial 2 4 2 7 5* 5 5 10 2 7 5 2II 57 Naja Naja 1000u/amp, China NAJA01 amp 2 4 2 8 2 4 4 4 2 8 4III 58 Russells Viper 0.64mg/ml Thailand RUSS01 vial 2 4 2 4 4 20 20 6 12 6III 59 Tiger Snake Antivenene Inj 3000u, Australia TIGE01 vial 1 1 1 4 4 6E. RADIATION EMERGENCY60 Aluminium Hydroxide Suspension 6% ALUM03 bot Y Y Y Y Y Y Y Y YI 61a Calcium Gluconate Inj. 10% x 10ml CALC16 vial Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y YI 61b Calcium Chloride Dihydrate Inj 10% x 10ml CALC08 Y Y Y Y Y Y Y Y YII 62 CaNa 2 EDTA (see item 2) CALC39 vial 6 7* 29 9 9 6 6 6 1I 63 Desferrioxamine (see item 5) DESF01 vial Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y YI 64 Dimercaprol Inj 50mg/ml x 2ml (see item 7) DIME09 amp Y Y Y Y Y Y Y Y Y Y Y Y Y65a DTPA - Diethylenetriamine Calcium salts CALC38 vial Ypenta-acetic acid inj. Zinc salts ZINC15 vial Y66 Ipecac. Syrup (see item 33) IPEC03 bot Y* Y Y Y Y Y Y67a Magnesium Sulphate Soln. 49.3% X 5ML MAGN11 amp67b MAGN13 amp Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y YI 68a Penicillamine (see also item 20) PENI04 tab Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y68b Potassium iodide tab 130mg POTA63 tab Y Y Y Y Y YIII 69ΔPrussian Blue (Potassium Ferric Ferrocyanide) 500mgPRUS01 cap 120 150 150 310I 70 Sodium Bicarbonate Inj. 8.4% X 100ML SODI07 vial Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y YF. IMMUNOGLOBULINS & ANTITOXINS71 Anti-D(RHO)Immunoglobulin Inj. 300mcg ANTI01 vial Y Y Y Y Y Y Y Y Y Y Y Y72 Anti- hepatitis B 2ml ANTI19 vial73 Antirabies Immunoglobulin Inj. 150iu/ml 2ml ANTI07 vial Y Y Y Y Y Y Y Y Y Y* Y Y YIII 74 Botulism Trivalent Antitoxin Δ BOTU04 vial 2 2 3 275 Botulism Type A Toxin Inj 100u BOTU03 vial Y Y Y Y Y Y Y Y Y Y Y 176 Diphtheria Antitoxin 10000u DIPH08 vial Y Y Y Y77a Hepatitis B Vaccine Inj. 20mcg/ml x 1ml (Engerix) HEPA12 vial Y Y Y Y Y Y Y Y Y Y Y* Y Y Y Y77b Hepatitis B Immunoglobulin Inj. 109u/0.5ml HEPA36 vial77c Hepatitis B Immunoglobulin Inj. 220u/1ml HEPA38 vial Y Y Y Y Y Y* Y Y77d Hepatitis B Inj prefilled Syringe 110 iu/0.5ml HEPA39 Y Y Y Y Y Y Y Y77e Hepatitis B Immunoglobulin Inj 220u/1ml HEPA40 vial Y Y Y Y
複本 Antidotes and emeg drug list to hosp revised 28 April 08 Page 3 of 6 PagesAntidotes and Emergency Drug List April 2008LEVEL § ANTIDOTES & DETOXIFYING AGENT UNIT AHNH CMC KWH NDH PMH POH PWH PYNEH QEH QMH RHTSK SJH TKO TMH UCH YCH HKPIC ※77f Hepatitis B Immunoglobulin im injection 220 iu/ml x 5ml HEPA43 Y Y Y Y Y Y Y Y Y Y78 Immunoglobulin(Human) IV Inj 3G NORM15 vial Y Y Y Y Y Y Y Y Y Y Y Y Y Y79 Rabies Vac. (Inactivated) Inj. 2.5iu RABI01 vial Y Y Y Y Y Y Y Y Y Y Y Y* Y Y Y Y80 Tetanus Adsorbed Vaccine Inj. 5ml TETA03 vial Y Y Y Y Y Y Y Y Y Y Y Y* Y Y Y Y81 Tetanus immuno Globulin, human prefilled syringe 250iu TETA10 syringe Y Y Y Y Y Y Y Y Y Y Y* Y YII 82 Stone Fish Anti-venom 2000u STON01 vial 1*+1 2 2 2 2 1II 83 Phentolamine Methanesulphonate Inj. 10mg/ml 1ml PHEN21 amp 8 5 20 8 14 25 29 21 8 22 16 11 6II 84 Octreotide Acetate Inj. 0.1mg/ml 1ml OCTR01 amp 20 138 638 20 28 129 319 189 189 402 745 923 99II 85 Octreotide Acetate 1ml Inj. 0.05mg/ml OCTR02 amp 21 666 21 36 139 139 60 50I 86 Physostigmine Salicylate Inj 1mg/ml x 2ml PHYS03 amp Y Y Y Y Y Y Y Y Y Y Y Y Y YI 87 Cyprohepatadine HCl 4mg/tab CYPR01 tab Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y88 Silymarine tab 70mg YKEYS§ : Levels of antidotes stock with reference to memo (Ref: HA820/130/4/7/3) issued by DD(PS) on 9 May 2006. Level I Items (in blue)- HA Acute Hospital Level;Level II Items (in green) - HA Cluster Level; Level III Items (inred) - HA Central Level.※ : Hong Kong Poison Information Centre (tel: 26351111 from 9am to 9pm OR tel: 35134125 from 9pm to 9am daΔ : For the use of Level III antidotes, prior consultation with the Hong Kong Poison Information Centre (HKPIC) is strongly advi*: Stocked in A&E and not in Pharmacy**: Stocked in OT only#: Stocked in ICU and not in Pharmacy^: Stocked only in Emergency Cupboard in 2nd Floor and not in Pharmacy(1): In ICU and not in PharmacyNote 1: Ipecacuanha Syr. Emetic (A.P.F.) = Ipeca. Liq. Extract 0.6ml/10ml = 12mg (total alkaloids)/10ml or BPItems deleted from the table:Agkistordon Actus Thailand (Agki 01)Amyl Nitrite vitrillae (Amyl 01)Anti-hepatitis B Immunoglobulin syringe 100iu/0.5ml(Anti23)Barium sulphate (Bari 01)Bungarus Multicinctus 8000u/amp (Bung01)Dimercaptopropone Sod Sulphonate Inj 50mg/ml x 5ml (Germany) (Dime21)Gas gangrene antitoxin (Gas 01)Hepatitis B Immunoglobulin Inj 200u/ml x 2ml (Hepa35)Hydrochloric Acid Dilute Inf 0.15N x 500ml (Hydr 34)Ipecacuanha Paed Mixt 14mg/10ml (=Ipeca Liq Extract 0.7ml/10ml=14mg total alkaloids/10ml)Isoprenaline inj 0.2mg/ml x 10ml (Isop 06)Malayan Pit Viper Antivene 2mg/ml (Mala04)Metaraminol Tartrate Inj 10mg/ml x 1 ml (meta04)Neostigmine metasulphite inj 12.5mg/5ml (Neos 05)Neostigmine metasulphite inj 1mg/mll (Neos 07)Nikethamide inj 25% x 1.5ml (Nike 01)Penicillamine cap 250mg (Peni 02)Pralidoxime chloride inj 50mg per ml x 10ml (Pral03)Protamine sulphate inj 10mg/ml x 10ml (Prot 02)Pyridoxine Inj 100mg/ml x 10ml (Pyri05)Sodium Bicarbonate + 0.01% EDTA Infusion 1.26% x 500ml (Sodi10)Sodium Calcium Edetate Inj 200mg/ml x 5ml (Sodi 10)
Page 2 and 3:
ForewordMedication safety and provi
Page 4 and 5:
Chapter 6 summarizes the specific r
Page 6 and 7:
Chapter 6Conclusions and Recommenda
Page 8 and 9:
CHAPTER ONETHE WORKING GROUPMEMBERS
Page 10 and 11:
CHAPTER TWOTHE PROGRESS REPORT2.1 P
Page 12 and 13:
CHAPTER THREEAREAS FOR IMPROVEMENT
Page 14 and 15:
Existing In-patient Drug Administra
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
CHAPTER FOURRECOMMENDED PRACTICES A
Page 24 and 25:
Drug Name4.11 There should be a hos
Page 26 and 27: Electronic prescribing (Medication
Page 28 and 29: 4.46 When the use of CM is permitte
Page 30 and 31: cytotoxic and central intravenous a
Page 32 and 33: 4.72 Special precautions should be
Page 34 and 35: 4.84 To prevent mixing up medicatio
Page 36 and 37: The Principle of Three checks and F
Page 38 and 39: 4.111 Three-way (red and blue) and
Page 40 and 41: or their discharge or death, should
Page 42 and 43: operational requirement but also it
Page 44 and 45: Quality Complaints on Pharmaceutica
Page 46 and 47: LEVELSHAHOCE / DTOOLS & MECHANISMDU
Page 48 and 49: Medication Incident Report<
Page 50 and 51: Continuing Education6.18 In order t
Page 52 and 53: APPENDICESAppendix 1Appendix 2Appen
Page 54 and 55: Hospital Authority Hospital No. : I
Page 56 and 57: Sensitivity:Prescription/ routewith
Page 58 and 59: Appendix 3aLists of HA-wide Approve
Page 60 and 61: DRUGTeniposideABBREVIATIONVM-26Thia
Page 62 and 63: Appendix 3b“Do Not Use Abbreviati
Page 64 and 65: Appendix 4Schedule for the Administ
Page 66 and 67: Appendix 5Mechanism for the Managem
Page 68 and 69: 4. As with all medications, there s
Page 70 and 71: Appendix 6HA Guideline on Safe Mana
Page 72 and 73: 2.1 Concentrated potassium chloride
Page 74 and 75: Appendix 7Supply of Antidotes and D
Page 78 and 79: Appendix 8Guidelines for Supply of
Page 80 and 81: substitution with other drugs in ac
Page 82 and 83: Appendix 9Samples of the Line Label
Page 84 and 85: Appendix 10Guidelines on the use of
Page 86 and 87: Appendix 11Guidelines on Patient Se
Page 88 and 89: Operational Guidelines7. The operat
Page 90 and 91: COC(N) Paper 12/2004Approved by COC
Page 92 and 93: 7.4 Evaluation Record and report th
Page 94 and 95: DISPOSAL OF HOSPITAL PHARMACEUTICAL
Page 96 and 97: Appendix 14Guidelines on the Handli
Page 98 and 99: Appendix 15Medication Incident <str
Page 100 and 101: Hospital Authority Medication Incid
Page 102 and 103: QUALITY ASSURANCE IN DRUG THERAPYHO
Page 104 and 105: Fig. 1: ADR voluntary reporting sys
Page 106 and 107: PROCEUDRE FOR QUALITY COMPLAINTSONP
Page 108: Part II Procurement Section, CPO1.
show all

2005 Edition Report on Drug Administration Procedure & Practices ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?